Combining Novel Agents for CLL

Jennifer Brown, MD, PhD

Video Categories: CLL

Dr. Jennifer R. Brown talks about combining novel agents for treating CLL as the next step to achieve longer remissions for patients. Until now, novel agents have only been used individually or in combination with antibodies. New studies are being designed to measure the efficacy of combining novel agents with each other for improved outcomes.
September 7, 2018

Misconceptions About Genetic and Genomic Testing

Dr Andrey Antov notes that there is often confusion around genetic and genomic testing, due in part to a lack of genetic counselors, high costs, and the rate of adoption of new technologies.

January 10, 2019

Is Immunotherapy Appropriate Here?

Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.